2010
DOI: 10.1007/s00216-010-3747-z
|View full text |Cite
|
Sign up to set email alerts
|

Visual screening for JAK2V617F mutation by a disposable dipstick

Abstract: During the last 5 years, it was discovered that the JAK2V617F somatic mutation is present in virtually all patients with polycythemia vera and a large proportion of patients with essential thrombocythemia, primary myelofibrosis, and refractory anemia with ring sideroblasts and thrombocytosis. As a result, JAK2V617F was incorporated as a new clonal marker in the 2008 revision of the WHO diagnostic criteria. Current methods for JAK2 genotyping include direct sequencing, pyrosequencing, allele-specific PCR with e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“…The signal visualization was realized by Au NPs conjugated with anti-biotin antibodies. The anti-digoxigenin antibody performance for test zone construction was evaluated in the previously mentioned study [ 34 ], as well as other independent studies [ 37 , 38 ]. Therefore, the same type of anti-digoxigenin antibody was utilized for the TZ-S construction in the present study.…”
Section: Resultsmentioning
confidence: 99%
“…The signal visualization was realized by Au NPs conjugated with anti-biotin antibodies. The anti-digoxigenin antibody performance for test zone construction was evaluated in the previously mentioned study [ 34 ], as well as other independent studies [ 37 , 38 ]. Therefore, the same type of anti-digoxigenin antibody was utilized for the TZ-S construction in the present study.…”
Section: Resultsmentioning
confidence: 99%
“…The detection is done using streptavidin at a control line and an antibody specific for digoxin at a detection line. 49 A very interesting device was proposed by Kim et al, combining a microfluidic reverse transcription PCR (RT-PCR) reactor with a LFA to detect H1N1 virus (Fig. 3B).…”
Section: Nucleic Acid Detectionmentioning
confidence: 99%
“…While this is appropriate for laboratory screening, it is not appropriate for point-of-care analysis. Ideally, mRNA, miRNA, and genetic analysis will need to be incorporated into a simple and easy-to-use device that requires minimal or no technical expertise, such as a microchip or dipstick [29, 30]. …”
Section: Molecular Markersmentioning
confidence: 99%